Drug Discovery Informatics Market: Global Opportunity Analysis and Industry Forecast 2022-2029 Market

Scientists while performing various researches to discover new treatments for various diseases generate and analyse vast amount of information related to drugs and indications. Discovery informatics utilizes various methods and approaches to in creating such knowledge base and help analyse such huge database to derive valuable insights used in drug discovery process.

Drug discovery is a process which requires a huge amount of information. Drug discovery informatics includes databases of various molecules and drugs which are used by various pharmaceutical companies to perform their research. Various software are used to manage and filter the databases. Drug discovery informatics makes use of IT platforms, vital information and other processes to improve and rise over challenges. This sector used modern improvised technology like data storage, processing the data, managing and analysing it.

Market scope and structure analysis:

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on drug discovery informatics market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The development of the drug discovery informatics is majorly effected by changes in the investment on the research and development, companies working more on the research sector especially on the rare diseases. New inventions in the field of silico tools which have synced computers with workflows to chemistry of drug which has helped stimulate the growth largely. Various pharmaceutical companies are shifting their interest towards drug discovery and the urgent need to limit the drug discovery and its impact on the cost for the drug development are resulting in the growth of the drug discovery informatics market.

Increasing use of technology and shift of approach towards research by pharmaceutical companies are helping boost the demand for drug discovery informatics market. Analysis on the spot by the use of such software is a key factor driving the global drug discovery informatics market.

Having said this,  it has been observed that is a lack of professionals who are well aware with this technology along with the cost of investment required to set up informatics software are the major reasons hampering the growth. We have also observed some unacceptable error rates in the databases and unsatisfied end-users as well as providers are the major setbacks for the market.

New product launches to flourish the market:

In 2018, Certara launched a new system of drug informatics system. This was the version 10 of D360.

Jubilant Biosys introduced a major capacity expansions for it drug discover business services in November 2019. Also, Jubilant collaborated with Orion Corporation to work on projects based on the drug discovery informatics market.

In May, 2019, Dassault Systems overtook Medidata Solution and acquired the clinical expertise and cloud-based solutions from them.

In September 2019, Evotec and Takeda Pharmaceutical Company Limited established a five drug discovery program with Evotec’s clinical experts for clinical development for multiple therapy areas.

Selvita has launched a new Development strategy for CROs and how they can plan to grow in the coming years.

Surge in usage in market:

Various pharmaceutical companies have been using this informatics system and softwares for pre clinical research in research and development, compound screening, lead identification and target identification. These companies also use informatics for streamlining the process of drug discovery. Rapid growth in the number of new pharmaceutical as well as biotechnology companies has resulted in the surge in usage of such systems. Well established CROs have also started using the databases resulting in high demand for the softwares.

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global drug discovery informatics market industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global drug discovery informatics market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global drug discovery informatics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Drug discovery informatics market research report:

• What are the leading market players active in the drug discovery informatics market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

 Drug Discovery Informatics Market: Global Opportunity Analysis and Industry Forecast 2020-2027 Report Highlights